A detailed history of Commonwealth Equity Services, LLC transactions in Vaxart, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 16,451 shares of VXRT stock, worth $9,541. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,451
Previous 16,621 1.02%
Holding current value
$9,541
Previous $11,000 27.27%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$0.58 - $0.99 $98 - $168
-170 Reduced 1.02%
16,451 $14,000
Q2 2024

Jul 31, 2024

BUY
$0.53 - $1.3 $110 - $270
208 Added 1.27%
16,621 $11,000
Q1 2024

Apr 29, 2024

BUY
$0.56 - $1.41 $3,555 - $8,952
6,349 Added 63.09%
16,413 $21,000
Q4 2023

Feb 06, 2024

SELL
$0.57 - $0.85 $2,522 - $3,762
-4,426 Reduced 30.55%
10,064 $6,000
Q3 2023

Oct 23, 2023

SELL
$0.69 - $0.85 $103 - $127
-150 Reduced 1.02%
14,490 $11,000
Q2 2023

Aug 10, 2023

BUY
$0.6 - $1.41 $90 - $211
150 Added 1.04%
14,640 $11,000
Q1 2023

May 11, 2023

SELL
$0.71 - $1.25 $142 - $250
-200 Reduced 1.36%
14,490 $10,000
Q4 2022

Feb 07, 2023

BUY
$0.75 - $2.24 $161 - $481
215 Added 1.49%
14,690 $14,000
Q3 2022

Nov 14, 2022

SELL
$2.09 - $4.5 $3,112 - $6,700
-1,489 Reduced 9.33%
14,475 $31,000
Q2 2022

Jul 19, 2022

BUY
$2.7 - $5.28 $2,670 - $5,221
989 Added 6.6%
15,964 $55,000
Q1 2022

May 04, 2022

SELL
$4.29 - $6.64 $35,594 - $55,092
-8,297 Reduced 35.65%
14,975 $75,000
Q4 2021

Jan 31, 2022

SELL
$5.77 - $7.96 $29,571 - $40,795
-5,125 Reduced 18.05%
23,272 $145,000
Q3 2021

Oct 29, 2021

SELL
$6.67 - $9.8 $3,495 - $5,135
-524 Reduced 1.81%
28,397 $225,000
Q2 2021

Aug 11, 2021

BUY
$5.06 - $10.78 $13,034 - $27,769
2,576 Added 9.78%
28,921 $216,000
Q1 2021

May 04, 2021

SELL
$5.64 - $23.33 $20,535 - $84,944
-3,641 Reduced 12.14%
26,345 $159,000
Q4 2020

Feb 11, 2021

BUY
$3.5 - $7.98 $104,951 - $239,288
29,986 New
29,986 $171,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.